Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 November 2023 | Story Reuben Maeko | Photo SUPPLIED
Prof Nyoni, Dr Omar Mohamed Al-Ansari and Dr James Campbell
Prof Nyoni hands over the Winterthur Doha Interprofessional Declaration to the President of Qatar University Dr Omar Mohamed Al-Ansari and the WHO Director for Health Workforce Dr James Campbell at the All Together Better Health Conference in Doha, Qatar.

A delegation of five academics from the University of the Free State (UFS) made significant contributions at the recently concluded All Together Better Health Conference (ATBH) in Doha, Qatar. Led by Prof Champion Nyoni, Senior Researcher in the UFS School of Nursing and current Chairperson of Interprofessional.Global, the team showcased their research to an international audience, further solidifying UFS’s commitment to advancing interprofessional education and collaborative practices. 

Engagement at the Conference

The esteemed UFS academics, including Dr Lizemari Hugo-van Dyk (School of Nursing), Dr Anke van der Merwe (School of Health and Rehabilitation Sciences), Dr Riaan van Wyk (Clinical Skills and Simulation Unit), and Dr Benjamin Botha (Computer Science and Informatics), actively participated in the conference, presenting their research findings to over 600 delegates from around the world. The ATBH Conference brought together students, educators, researchers, and policymakers with a shared goal of advancing interprofessional education and collaborative practices. 

UFS’s leading role in Interprofessional Education

Interprofessional education (IPE), the focal point of the conference, involves collaborative learning among students from multiple health and social care professions. The UFS has been a trailblazer in the IPE domain, boasting a robust IPE programme that has been running successfully for nearly a decade.

Leadership excellence by Prof Nyoni

Prof Nyoni, as the Chair of Interprofessional. Global, played a pivotal role in the conference, showcasing leadership and communication excellence on a global scale. Interprofessional. Global is a confederation of regional networks worldwide purposed to embed IPE as part of mainstream training for the health workforce globally. His welcome address during the grand opening ceremony, attended by esteemed dignitaries including Her Highness Sheika Moza bint Nasser, the President of Qatar University, and the Director for Health Workforce at the World Health Organization (WHO), marked a momentous occasion. Moreover, Prof Nyoni presented the Winterthur-Doha Interprofessional Declaration to Qatar University and the WHO, symbolically endorsing IPE as a strategy to enhance global health outcomes. 

The Winter-Doha Interprofessional Declaration

Explaining the significance of the Winter-Doha Interprofessional Declaration, Prof Nyoni expressed his excitement, stating, “I am thrilled that the World Health Organisation was forthcoming to receive this declaration – symbolically endorsing IPE as a strategy to enhance our health outcomes.” He added that this declaration would influence global efforts towards true IPE integration, with global representatives within the IPE community contributing to this milestone. 

Research presentations by UFS Academics

The UFS academics delivered impactful presentations at the conference. Drs Hugo-van Dyk and Botha, along with Prof Nyoni, discussed “An Online Programme for Clinical Facilitators in Health Professions Education: A missed opportunity for IPE.” Additionally, they presented on desktop-based virtual reality to enhance role clarification in interprofessional education. Drs Van der Merwe and Van Wyk, along with Prof Nyoni, presented “Educator needs regarding a simulation debriefing programme: A missed opportunity for interprofessional practice at a South African University.” 

Global collaboration and appreciation 

Dr Botha, a member of the African Interprofessional Education Network (AfrlPEN), expressed appreciation for the opportunity, stating, “We have made good milestones globally and we are committed to continue to impact and influence the global space.” Dr van der Merwe echoed this sentiment, acknowledging the chance to connect with like-minded professionals worldwide and expressing gratitude to the UFS for facilitating this opportunity. 

Closing thoughts 

The UFS delegation’s active participation at the ATBH Conference not only underscores the university's commitment to advancing interprofessional education but also reinforces its global leadership in this critical domain. The contributions made at this prestigious event exemplify the UFS’s dedication to collaborative practices that enhance healthcare outcomes on a global scale. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept